Literature DB >> 16501580

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.

Leon Chang1, Lin Luo, James A Palmer, Steven Sutton, Sandy J Wilson, Ann J Barbier, James Guy Breitenbucher, Sandra R Chaplan, Michael Webb.   

Abstract

1 The reversible fatty acid amide hydrolase (FAAH) inhibitor OL135 reverses mechanical allodynia in the spinal nerve ligation (SNL) and mild thermal injury (MTI) models in the rat. The purpose of this study was to investigate the role of the cannabinoid and opioid systems in mediating this analgesic effect. 2 Elevated brain concentrations of anandamide (350 pmol g(-1) of tissue vs 60 pmol g(-1) in vehicle-treated controls) were found in brains of rats given OL135 (20 mg kg(-1)) i.p. 15 min prior to 20 mg kg(-1) i.p. anandamide. 3 Predosing rats with OL135 (2-60 mg kg(-1) i.p.) 30 min before administration of an irreversible FAAH inhibitor (URB597: 0.3 mg kg(-1) intracardiac) was found to protect brain FAAH from irreversible inactivation. The level of enzyme protection was correlated with the OL135 concentrations in the same brains. 4 OL135 (100 mg kg(-1) i.p.) reduced by 50% of the maximum possible efficacy (MPE) mechanical allodynia induced by MTI in FAAH(+/+)mice (von Frey filament measurement) 30 min after dosing, but was without effect in FAAH(-/-) mice. 5 OL135 given i.p. resulted in a dose-responsive reversal of mechanical allodynia in both MTI and SNL models in the rat with an ED(50) between 6 and 9 mg kg(-1). The plasma concentration at the ED(50) in both models was 0.7 microM (240 ng ml(-1)). 6 In the rat SNL model, coadministration of the selective CB(2) receptor antagonist SR144528 (5 mg kg(-1) i.p.), with 20 mg kg(-1) OL135 blocked the OL135-induced reversal of mechanical allodynia, but the selective CB(1) antagonist SR141716A (5 mg kg(-1) i.p.) was without effect. 7 In the rat MTI model neither SR141716A or SR144528 (both at 5 mg kg(-1) i.p.), or a combination of both antagonists coadministered with OL135 (20 mg kg(-1)) blocked reversal of mechanical allodynia assessed 30 min after dosing. 8 In both the MTI model and SNL models in rats, naloxone (1 mg kg(-1), i.p. 30 min after OL135) reversed the analgesia (to 15% of control levels in the MTI model, to zero in the SNL) produced by OL135.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501580      PMCID: PMC1617043          DOI: 10.1038/sj.bjp.0706699

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  64 in total

1.  Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.

Authors:  L J Drew; J Harris; P J Millns; D A Kendall; V Chapman
Journal:  Eur J Neurosci       Date:  2000-06       Impact factor: 3.386

Review 2.  Naturally occurring antinociceptive substances from plants.

Authors:  J B Calixto; A Beirith; J Ferreira; A R Santos; V C Filho; R A Yunes
Journal:  Phytother Res       Date:  2000-09       Impact factor: 5.878

3.  Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.

Authors:  Aron H Lichtman; Donmienne Leung; Christopher C Shelton; Alan Saghatelian; Christophe Hardouin; Dale L Boger; Benjamin F Cravatt
Journal:  J Pharmacol Exp Ther       Date:  2004-06-30       Impact factor: 4.030

4.  Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study.

Authors:  Estefanía Núñez; Cristina Benito; M Ruth Pazos; Antonio Barbachano; Otto Fajardo; Sara González; Rosa M Tolón; Julián Romero
Journal:  Synapse       Date:  2004-09-15       Impact factor: 2.562

Review 5.  The neurobiology and evolution of cannabinoid signalling.

Authors:  M R Elphick; M Egertová
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-03-29       Impact factor: 6.237

6.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA.

Authors:  L A Matsuda; S J Lolait; M J Brownstein; A C Young; T I Bonner
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

7.  Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons.

Authors:  J Ahluwalia; L Urban; M Capogna; S Bevan; I Nagy
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

8.  Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Authors:  Marco Mor; Silvia Rivara; Alessio Lodola; Pier Vincenzo Plazzi; Giorgio Tarzia; Andrea Duranti; Andrea Tontini; Giovanni Piersanti; Satish Kathuria; Daniele Piomelli
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

9.  Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.

Authors:  Aron H Lichtman; Christopher C Shelton; Tushar Advani; Benjamin F Cravatt
Journal:  Pain       Date:  2004-06       Impact factor: 6.961

10.  The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans.

Authors:  E A Carlini
Journal:  Toxicon       Date:  2004-09-15       Impact factor: 3.033

View more
  79 in total

Review 1.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

2.  Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Authors:  Iryna A Khasabova; Sergey Khasabov; Justin Paz; Catherine Harding-Rose; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.

Authors:  Andrew J Kwilasz; Rehab A Abdullah; Justin L Poklis; Aron H Lichtman; Sidney S Negus
Journal:  Behav Pharmacol       Date:  2014-04       Impact factor: 2.293

5.  Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.

Authors:  Farinaz Nasirinezhad; Stanislava Jergova; James P Pearson; Jacqueline Sagen
Journal:  Neuropharmacology       Date:  2014-12-05       Impact factor: 5.250

6.  Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Authors:  Katerina Otrubova; Monica Brown; Michael S McCormick; Gye W Han; Scott T O'Neal; Benjamin F Cravatt; Raymond C Stevens; Aron H Lichtman; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-04-12       Impact factor: 15.419

7.  Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms.

Authors:  S Maione; E Morera; I Marabese; A Ligresti; L Luongo; G Ortar; V Di Marzo
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

8.  Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.

Authors:  Venkatesh L Hegde; Shweta Hegde; Benjamin F Cravatt; Lorne J Hofseth; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Mol Pharmacol       Date:  2008-04-03       Impact factor: 4.436

9.  A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.

Authors:  Laura Bertolacci; Elisa Romeo; Marina Veronesi; Paola Magotti; Clara Albani; Mauro Dionisi; Chiara Lambruschini; Rita Scarpelli; Andrea Cavalli; Marco De Vivo; Daniele Piomelli; Gianpiero Garau
Journal:  J Am Chem Soc       Date:  2012-12-21       Impact factor: 15.419

10.  Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain.

Authors:  Russell P Landry; Elena Martinez; Joyce A DeLeo; E Alfonso Romero-Sandoval
Journal:  J Pain       Date:  2012-08-14       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.